Mary Kay Fenton

2010 - Achillion Pharmaceuticals

In 2010, Mary Kay Fenton earned a total compensation of $788.1K as Senior Vice President and Chief Financial Officer at Achillion Pharmaceuticals, a 103% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$90,406
Option Awards$426,760
Salary$263,222
Other$7,673
Total$788,061

Fenton received $426.8K in option awards, accounting for 54% of the total pay in 2010.

Fenton also received $90.4K in non-equity incentive plan, $263.2K in salary and $7.7K in other compensation.

Rankings

In 2010, Mary Kay Fenton's compensation ranked 6,172nd out of 10,439 executives tracked by ExecPay. In other words, Fenton earned more than 40.9% of executives.

ClassificationRankingPercentile
All
6,172
out of 10,439
41st
Division
Manufacturing
2,220
out of 3,838
42nd
Major group
Chemicals And Allied Products
491
out of 926
47th
Industry group
Drugs
307
out of 685
55th
Industry
Pharmaceutical Preparations
228
out of 481
53rd
Source: SEC filing on April 12, 2013.

Fenton's colleagues

We found five more compensation records of executives who worked with Mary Kay Fenton at Achillion Pharmaceuticals in 2010.

2010

Michael Kishbauch

Achillion Pharmaceuticals

Chief Executive Officer

2010

Milind Deshpande

Achillion Pharmaceuticals

Chief Scientific Officer

2010

Joseph Truitt

Achillion Pharmaceuticals

Senior Vice President and Chief Commercial Officer

2010

Gautam Shah

Achillion Pharmaceuticals

Executive Vice President and Chief Compliance Officer

2010

Elizabeth Olek

Achillion Pharmaceuticals

Chief Medical Officer

News

In-depth

You may also like